Aligos Therapeutics Inc
NASDAQ:ALGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
|
Co-Diagnostics Inc
NASDAQ:CODX
|
US |
|
Central Security Patrols Co Ltd
TSE:9740
|
JP |
|
T
|
Thiensurat PCL
SET:TSR
|
TH |
|
Firstcash Holdings Inc
NASDAQ:FCFS
|
US |
|
Lithium Americas Corp
TSX:LAC
|
CA |
|
Native Mineral Resources Holdings Ltd
ASX:NMR
|
AU |
|
T
|
Telus Corp
NYSE:TU
|
CA |
|
George Weston Ltd
TSX:WN
|
CA |
|
M
|
Magellan Health Inc
F:MAH1
|
US |
Wall Street
Price Targets
ALGS Price Targets Summary
Aligos Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ALGS
is 39.27 USD
with a low forecast of 20.2 USD and a high forecast of 52.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALGS's stock price target?
Price Target
39.27
USD
According to Wall Street analysts, the average 1-year price target for
ALGS
is 39.27 USD
with a low forecast of 20.2 USD and a high forecast of 52.5 USD.
What is Aligos Therapeutics Inc's Revenue forecast?
Projected CAGR
159%
The
compound annual growth rate
of Aligos Therapeutics Inc's revenue for the next 3 years is
159%.
